Put AI agents to work on pharmacovigilance and output goes up. So does a quieter risk: the experts who are supposed to supervise those agents slowly lose the ability to do the work themselves.
Dr. Henry Seto, our Chief Medical Officer, and Dr. Jan Petracek, our CEO, talk through what AI in pharmacovigilance really changes for the people doing the job. iVigee is implementing AI agents across the business, with experts moving into supervisory roles. The catch is simple. To supervise, you have to know the job, know what the machine is doing, and know where the pitfalls are. That only comes from hands-on experience.
The conversation covers:
Technology is not 100% reliable, and PV still needs business continuity. If your team is handing more work to AI, the real question is whether your people could still step in if the agents stopped working.
Got a pharmacovigilance question of your own? Put it to our experts


Hvezdova 1716/2b, 140 00 Prague 4, Czech Republic
1500 District Avenue, Burlington, MA, United States